Venous Thromboembolism News and Research

RSS

Long-term study supports cardiovascular safety of contemporary hormone replacement therapy

Contemporary hormone replacement therapy (HRT) was not associated with an increased risk for heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of over 52,000 women in Israel.

2 Nov 2026

New score predicts thrombosis risk in hospitalized pancreatitis patients

Professor Julia Mayerle and colleagues from LMU University Hospital Munich have developed an admission-based score intended to identify pancreatitis patients more likely to be diagnosed with thrombosis during hospitalization.

28 Oct 2026

Hēlo system offers minimally invasive solution for chronic venous thromboembolism

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated.

27 Oct 2026

Study links recreational cannabis legalization to rising heart attack admissions

Legalization of recreational cannabis in the US is associated with a rise in hospital admissions for cardiovascular disease, finds an analysis of more than 50 million patient discharge records, published in the open access journal BMJ Open.

22 Oct 2026

Cannabis users face increased heart attack risk around surgery

As marijuana use becomes more common and legal in most U.S. states, patients who use cannabis may face a significantly higher risk of heart attack around the time of surgery, while also showing an unexpected lower risk of dangerous blood clots in the veins, suggests a study presented at the ANESTHESIOLOGY® 2026 annual meeting.

19 Oct 2026

Coffee drinkers had fewer repeat blood clots in a Norwegian study

A Norwegian study involving 2,071 patients found that those who reported drinking 1 to 2 cups of coffee daily before their first venous thromboembolism had a 51% lower estimated risk of recurrence than non-drinkers. The association was strongest among patients whose initial blood clot was provoked, although the observational study could not establish that coffee consumption prevents recurrence.

14 Oct 2026

Study finds oral hormone replacement therapy increases venous thromboembolism risk

Current use of oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is associated with an increased risk of blood clots in legs / lungs regardless of dose or treatment duration, finds a large Danish study published by The BMJ today.

23 Sep 2026

More major insurance companies covering Kerecis intact fish-skin grafts as new studies show big benefits for burns and diabetic foot ulcers

Kerecis, the company pioneering the use of sustainably sourced fish‑skin grafts in cellular therapy and tissue regeneration, has significantly expanded U.S. insurance coverage, adding more than 40 million covered lives through recent policy updates across multiple large national and regional insurers, as well as state Medicaid programs.

3 Sep 2026

Review explores complex links between obesity and cardiovascular diseases

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obesity, given its strong association with cardiovascular diseases (CVDs), is a major global public health issue attracting increasing attention.

27 Aug 2026

Multiple long-term conditions raise pregnancy risks, study finds

Women who begin pregnancy with two or more pre-existing, long-term physical or mental health conditions have 20% higher risk of miscarriage, 69% higher risk of severe nausea and vomiting, and around four times the risk of anxiety and depression, compared with those with no long-term conditions.

18 Aug 2026

Severe COVID-19 reactivates dormant viruses and may leave a lasting viral signature

A longitudinal study of 1,154 hospitalized COVID-19 patients found widespread reactivation of chronic Herpesviridae and Anelloviridae, with distinct viral patterns linked to disease severity, inflammation, and clinical outcomes. Anelloviridae also persisted during convalescence and were associated with physical deficits in long COVID, although the study did not establish causation.

7 Aug 2026

AI uncovers hidden molecular signals linked to thrombosis risk

Two people may be the same age and have similar family histories or risk factors, yet only one of them may develop thrombosis.

6 Jul 2026

Mechanical restraint may increase short-term blood clot risk in psychiatric patients

Mechanical restraint is associated with a small increased short term risk of blood clots among inpatients at psychiatric hospitals, finds a Danish study published by The BMJ today.

1 Jul 2026

GLP-1 medicines may cut clot-related risks in chronically inflamed patients

In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism, venous thromboembolism, stroke/TIA, emergency department visits, and all-cause mortality.

10 Jun 2026

GLP-1 therapies linked to fewer complications in adults with both obesity and autoimmune disease

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

7 Jun 2026

EULAR 2026 highlights rising comorbidity risks in rheumatic disease

People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures.

4 Jun 2026

Higher genetic pulse pressure risk associated with dementia-related mortality

When looking at genetic variants in a person's DNA that predispose them to disease, a new study has found having a higher number of genetic variants for increased pulse pressure is associated with a small, increased risk of dementia as a contributing cause of death.

3 Jun 2026

Pregnancy magnifies heart risk, but age alone does not explain why

A large U.S. cohort-crossover study found that pregnancy and the postpartum period were linked to about a seven-fold higher relative risk of major adverse cardiovascular events compared with patients’ nonpregnant baseline risk. This relative risk increase did not vary by maternal age, suggesting pregnancy broadly amplifies existing cardiovascular risk rather than making older age itself the driver of pregnancy-specific cardiovascular complications.

20 May 2026

New genetic risk report reveals hidden heart disease risk before symptoms appear

Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using large U.S.-based biobank data. The clinically orderable report may help identify inherited cardiovascular risk that traditional clinical markers can miss, although broader prospective validation is still needed.

30 Apr 2026

New genetic risk test estimates inherited risk for cardiovascular conditions

Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person's inherited risk for eight common cardiovascular conditions, offering a more comprehensive approach to prevention.

29 Apr 2026